Fact: PBMs leverage competition and negotiate rebates from drug manufacturers to lower drug costs.
Rebates not to blame for rising drug costs, says PBM trade group
June 15, 2017
Drug Prices Become Target for FDA as Chief Expands Purview
June 06, 2017
A Market-Based Plan for Affordable Prescription Drugs
May 18, 2017